The aim of this study was to evaluate the influence of selected neuropeptides on itching in psoriatic individuals. Fifty-nine patients (43 pruritic and 16 non-pruritic) with psoriasis were included in the study. The severity of psoriasis, measured using the Psoriasis Area and Severity Index scale, ranged between 2 and 43.7 points. The intensity of pruritus was evaluated using a Visual Analogue Scale. The plasma levels of substance P, vasoactive intestinal peptide, calcitonin gene-related peptide and neuropeptide Y were measured radioimmunologically. The plasma level of neuropeptide Y was significantly decreased in patients with pruritus compared with those without pruritus (21.6 +/- 39.6 pg/ml and 144.3 +/- 385.7 pg/ml, respectively; p=0.03). Levels of other neuropeptides did not differ significantly between pruritic and non-pruritic patients; however, a tendency to lower plasma levels of substance P and vasoactive intestinal peptide in patients with itching was noted. Moreover, a significant negative correlation was observed between pruritus severity and levels of substance P (r = -0.36; p=0.02), as well as between pruritus severity and plasma levels of vasoactive intestinal peptide (r = -0.34; p=0.03). The imbalance of neuropeptide activity in the sera of pruritic subjects may suggest a role for neuropeptides in perception of itching in psoriatic individuals.
Significant overexpression of VAP-1 in both lesional and non-lesional psoriatic skin and higher serum level of soluble VAP-1 in psoriatic patients may indicate the role of VAP-1 in chronic inflammation occurring in psoriasis. However, because of lack of correlation between soluble VAP-1 serum levels and psoriasis severity this hypothesis needs further investigation.
Background: Many patients with psoriasis suffer from itch. The pathogenesis of psoriatic itch still remains unknown. Objective: To evaluate the relationships between plasma levels of histamine, substance P (SP) and calcitonin gene-related peptide (CGRP) and the presence as well as intensity of itching among psoriatic patients. Patients and Methods: 59 psoriatic individuals (43 pruritic and 16 non-pruritic) and 32 healthy controls were included in the study. Itching was evaluated by a visual analog scale (VAS) and a specially designed questionnaire. Plasma concentrations of histamine, SP and CGRP were measured by RIA (radioimmunoassay) method. Results: The mean plasma concentration of histamine in psoriatic patients was not significantly different from that found in controls. No significant differences were found between plasma levels of histamine in the groups of psoriatic pruritic patients, non-pruritic psoriatics and controls. Also, there was no significant difference in SP plasma concentration between psoriatic individuals and controls or between pruritic, non-pruritic and healthy people. No relationships between the substances studied (histamine, SP) and intensity of pruritus could be revealed. The mean CGRP plasma level was markedly increased in patients suffering from psoriasis as compared to controls (p < 0.01). The mean CGRP concentration in the plasma of pruritic psoriatic patients was significantly higher than in controls (p < 0.01). This was not observed when comparing non-pruritic to healthy subjects. The mean concentration of CGRP in the plasma of pruritic patients was also higher than in that of non-pruritic ones, but this difference did not reach statistical significance. A significant correlation was found between itching intensity and CGRP plasma concentration in male subjects and in those patients who had been suffering from psoriasis for 5–20 years. There were, however, no correlations between CGRP level and itching intensity in the whole group of 43 psoriatic patients with pruritus. Conclusion: Circulatory CGRP could be an important factor in the pathogenesis of psoriatic pruritus, but this still needs further investigation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.